IMNM CIK: 1472012

Immunome Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
56.6
FY22:
22.6
FY23:
145
FY24:
221
FY25:
661
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.29
FY22:
1.40
FY23:
3.84
FY24:
18.9
FY25:
22.4
Total assets
Change from FY21 to FY25
millions USD
FY21:
57.9
FY22:
24.0
FY23:
149
FY24:
240
FY25:
683

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
9.73
FY22:
7.33
FY23:
21.8
FY24:
54.3
FY25:
45.0
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
0.06
FY23:
6.83
FY24:
4.77
FY25:
3.86
(positive)
Change from FY21 to FY25
millions USD
FY21:
48.2
FY22:
16.7
FY23:
120
FY24:
181
FY25:
634
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
57.9
FY22:
24.0
FY23:
149
FY24:
240
FY25:
683

All amounts in millions USD Data source:SEC EDGAR